Brief: Prostatype Genomics Q1 EBITDA Loss At 5.1 Mln

Prostatype Genomics AB

12/05/2022 07:23

May 12 (Reuters) - Prostatype Genomics AB  PROGEN.ST :
    * Q1 NET SALES AMOUNTED TO 264 TSEK.
    * Q1 EBITDA (EARNINGS BEFORE INTEREST, TAXES, DEPRECIATION,
AND
AMORTIZATION) AMOUNTED TO - 5 050 TSEK.

Source text for Eikon:  ID:nWkr91Hkvl 
Further company coverage:  PROGEN.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))